Chart of the Day: Incyte (INCY)

NASDAQ: INCY | Incyte Corporation News, Ratings, and Charts

INCY – INCY has hit a ceiling at $110. Look for when the stock closes above this resistance level.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Incyte Corp. (INCY) has been trending higher since hitting its 52-week low on March 23rd.  Yet, now the rally has stalled and a key resistance level has formed.

INCY focuses on the discovery and development of small-molecule drugs. The company’s lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease. The company last week announced positive results from a Phase 3 clinical trial, REACH3, that evaluated Jakafi in patients with moderate or severe steroid-refractory or steroid dependent chronic graft-versus-host disease (GvHD).

Take a look at the 1-year chart of INCY below with added notations: 

Chart of INCY provided by TradingView

As you can see in the chart above, there is a resistance level that has formed at $110 (red) and was tested on three separate occasions. $110 is also the 52 week high for INCY.  A trader could buy the stock after a solid close above the resistance level with the expectation of a breakout.

Keep an eye out on August 4th for INCY’s latest earnings report. 

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach

Want More Great Investing Ideas?

5 WINNING Stock Charts  

9 “BUY THE DIP” Growth Stocks for 2020

Newly REVISED 2020 Stock Market Outlook

7 “Safe-Haven” Dividend Stocks for Turbulent Times


INCY shares were trading at $101.95 per share on Monday morning, up $2.53 (+2.54%). Year-to-date, INCY has gained 16.75%, versus a 1.24% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
INCYGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Top Stories on StockNews.com

: uber | Uber Technologies, Inc.  News, Ratings, and Charts

Betting On A Big Move In Uber

UBER or LYFT? Which Rideshare Service is Best For Traders?
NYSE: XOM | Exxon Mobil Corporation  News, Ratings, and Charts

Not All Stock Yields Are the Same

The lowest treasury bond in over 2 centuries has some stocks still in prime position like: XOM and PSA.
NYSE: AJG | Arthur J. Gallagher & Co.  News, Ratings, and Charts

3 Stocks that Wall Street Analysts Recommend to Buy

Analyst ratings can help investors make informed decisions on stocks. Here are four buy-rated stocks to consider: Arthur J. Gallagher & Co. (AJG), Brunswick Corp (BC), and Bandwidth (BAND).
NASDAQ: JD | JD.com, Inc. News, Ratings, and Charts

4 International E-Commerce Stocks You Need to Know About

The e-commerce market has been soaring as coronavirus fears have kept shoppers indoors. Here are four international e-commerce stocks riding the online shopping wave: JD.com (JD), MercadoLibre (MELI), Sea Limited (SE), and Jumia Technologies (JMIA).
NASDAQ: NFLX | Netflix, Inc. News, Ratings, and Charts

The Best FAANG Stock to Own This Month

Why I believe that of the five stocks that comprise the acronym FAANG, Netflix (NFLX) is the stock to own in August.

Read More Stories


More Incyte Corporation (INCY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All INCY News